Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 5/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 3/6 |
Beauty Farm Medical and Health Industry Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$1.90 |
52 Week High | HK$1.96 |
52 Week Low | HK$1.17 |
Beta | 0 |
11 Month Change | -0.52% |
3 Month Change | 9.20% |
1 Year Change | 18.01% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -39.59% |
Recent News & Updates
Recent updates
Shareholder Returns
XC5 | DE Consumer Services | DE Market | |
---|---|---|---|
7D | -1.6% | 6.5% | -2.2% |
1Y | 18.0% | 22.4% | 13.3% |
Return vs Industry: XC5 underperformed the German Consumer Services industry which returned 22% over the past year.
Return vs Market: XC5 exceeded the German Market which returned 13.6% over the past year.
Price Volatility
XC5 volatility | |
---|---|
XC5 Average Weekly Movement | 2.6% |
Consumer Services Industry Average Movement | 5.2% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: XC5 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: XC5's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1993 | 3,925 | Songyong Lian | www.beautyfarm.com.cn |
Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People’s Republic of China It offers traditional beauty services; aesthetic medical services, including non-surgical aesthetic medical services, such as energy-based services and injection services, as well as surgical aesthetic medical services; and subhealth assessment and intervention services. As of June 30, 2022, the company operated 352 stores, including 177 direct stores and 175 franchised stores under the BeautyFarm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People’s Republic of China.
Beauty Farm Medical and Health Industry Inc. Fundamentals Summary
XC5 fundamental statistics | |
---|---|
Market cap | €473.61m |
Earnings (TTM) | €28.39m |
Revenue (TTM) | €290.86m |
16.7x
P/E Ratio1.6x
P/S RatioIs XC5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
XC5 income statement (TTM) | |
---|---|
Revenue | CN¥2.25b |
Cost of Revenue | CN¥1.21b |
Gross Profit | CN¥1.03b |
Other Expenses | CN¥813.95m |
Earnings | CN¥219.25m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.93 |
Gross Margin | 46.00% |
Net Profit Margin | 9.76% |
Debt/Equity Ratio | 7.2% |
How did XC5 perform over the long term?
See historical performance and comparison